In Australia, Collagen Solutions PLC, which is registered in London and has global headquarters in Minnesota, received additional patent protection. The patent allows Collagen to source animal-based biomaterials from Australia for their pericardium tissue for heart valve replacements, orthopedics, dental industry, wound healing, surgery, and other medical uses. Australia and New Zealand are often sought-after by companies looking for high quality animal-based biomaterials because they have strict controls and have been doing it for a long time. Collagen’s CEO, Jamal Rushdy, told Proactive Investors UK, “This recent patent further strengthens our position in sourcing tissue in Australia in a novel way. We believe the additional processing covered in this patent will be of significant interest to our existing customer base.”
Latest article
Kiwi company turns kiwi waste into leather
In New Zealand, a startup called KiwiLeather Innovations is building a business converting rejected kiwifruit into a leather alternative.
According to Fresh Plaza, over...
UPSIDE Foods serves cultivated chicken at Indy 500 ahead of state ban
In Indiana, UPSIDE Foods served cultivated chicken sandwiches during the recent Indianapolis 500 as it called the state’s upcoming ban on such products “un-American.”...
Bee-free honey maker MeliBio acquired by FoodYoung Labs
In California, MeliBio, a pioneer in bee-free food, has been acquired by Switzerland-based foodtech FoodYoung Labs for an undisclosed sum.
MeliBio has earned global...